|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 06:15PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 06:28PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
3
|
Resverlogix Corp.
|
Jan 14, 2019 07:28PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 07:49PM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
3
|
Resverlogix Corp.
|
Jan 15, 2019 04:41PM
|
|
Re: Risk vs Reward moving forward!
|
17
|
Resverlogix Corp.
|
Dec 17, 2021 03:09PM
|
|
Re: Reverse Split, the good, bad and in between....
|
4
|
Resverlogix Corp.
|
Aug 15, 2018 02:13PM
|
|
Re: Reverse Split, the good, bad and in between....
|
2
|
Resverlogix Corp.
|
Aug 16, 2018 11:11AM
|
|
Re: Reverse Split, the good, bad and in between....
|
1
|
Resverlogix Corp.
|
Aug 16, 2018 03:19PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 06, 2019 06:04PM
|
|
Re: Revamped website
|
3
|
Resverlogix Corp.
|
Jan 06, 2019 07:23PM
|
|
Re: Revamped website
|
3
|
Resverlogix Corp.
|
Jan 06, 2019 08:49PM
|
|
Re: Revamped website
|
2
|
Resverlogix Corp.
|
Jan 06, 2019 09:26PM
|
|
Re: Revamped website
|
6
|
Resverlogix Corp.
|
Jan 06, 2019 09:57PM
|
|
Re: Resverlogix NYAS Symposium notes
|
2
|
Resverlogix Corp.
|
Apr 29, 2016 05:59PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
4
|
Resverlogix Corp.
|
Apr 19, 2022 06:42PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
9
|
Resverlogix Corp.
|
Apr 19, 2022 07:14PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
8
|
Resverlogix Corp.
|
Dec 22, 2020 01:03PM
|
|
Re: Resverlogix and Zenith AGMs
|
1
|
Resverlogix Corp.
|
Aug 23, 2016 11:31AM
|
|
Re: Resverlogix and Zenith AGMs
|
1
|
Resverlogix Corp.
|
Aug 23, 2016 11:54AM
|
